JP2025515002A5 - - Google Patents
Info
- Publication number
- JP2025515002A5 JP2025515002A5 JP2024564484A JP2024564484A JP2025515002A5 JP 2025515002 A5 JP2025515002 A5 JP 2025515002A5 JP 2024564484 A JP2024564484 A JP 2024564484A JP 2024564484 A JP2024564484 A JP 2024564484A JP 2025515002 A5 JP2025515002 A5 JP 2025515002A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- group
- ring
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337344P | 2022-05-02 | 2022-05-02 | |
| US63/337,344 | 2022-05-02 | ||
| US202363481045P | 2023-01-23 | 2023-01-23 | |
| US63/481,045 | 2023-01-23 | ||
| PCT/US2023/020546 WO2023215220A1 (en) | 2022-05-02 | 2023-05-01 | Macrocyclic inhibitors of atp citrate lyase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515002A JP2025515002A (ja) | 2025-05-13 |
| JP2025515002A5 true JP2025515002A5 (enExample) | 2026-05-12 |
Family
ID=86776394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564484A Pending JP2025515002A (ja) | 2022-05-02 | 2023-05-01 | Ａｔｐクエン酸リアーゼのマクロ環式阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250289793A1 (enExample) |
| EP (1) | EP4519251A1 (enExample) |
| JP (1) | JP2025515002A (enExample) |
| KR (1) | KR20250004873A (enExample) |
| CN (1) | CN119137107A (enExample) |
| AU (1) | AU2023264491A1 (enExample) |
| CA (1) | CA3251749A1 (enExample) |
| IL (1) | IL316386A (enExample) |
| WO (1) | WO2023215220A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL328133A (en) * | 2023-11-01 | 2026-06-01 | Esperion Therapeutics Inc | Macrocyclic inhibitors of atp citrate lyase |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| WO2020097408A1 (en) * | 2018-11-09 | 2020-05-14 | Nimbus Artemis, Inc. | Acly inhibitors and uses thereof |
| CN115677616B (zh) * | 2021-11-03 | 2024-10-18 | 中国药科大学 | 大环磺酰胺类化合物及其制备方法和医药用途 |
-
2023
- 2023-05-01 WO PCT/US2023/020546 patent/WO2023215220A1/en not_active Ceased
- 2023-05-01 CA CA3251749A patent/CA3251749A1/en active Pending
- 2023-05-01 JP JP2024564484A patent/JP2025515002A/ja active Pending
- 2023-05-01 EP EP23731394.5A patent/EP4519251A1/en active Pending
- 2023-05-01 IL IL316386A patent/IL316386A/en unknown
- 2023-05-01 KR KR1020247039451A patent/KR20250004873A/ko active Pending
- 2023-05-01 CN CN202380038044.0A patent/CN119137107A/zh active Pending
- 2023-05-01 US US18/862,295 patent/US20250289793A1/en active Pending
- 2023-05-01 AU AU2023264491A patent/AU2023264491A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5795402B2 (ja) | 新規抗血小板薬 | |
| JP2013509431A5 (enExample) | ||
| JP2024501562A (ja) | 一連のピペリジン置換安息香酸系化合物及びその使用 | |
| JP2014520898A5 (enExample) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP7707451B2 (ja) | Ｎｏｄ様受容体タンパク質３の阻害剤として有用なフタラジン誘導体 | |
| HRP20150702T1 (hr) | Supstituirani 4-aril-1,4-dihidro-1,6-naftiridinamidi i njihova uporaba | |
| JP2019069941A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2018535963A5 (enExample) | ||
| JP2011500562A5 (enExample) | ||
| RU2009120389A (ru) | Гетероциклические соединения в качестве противовоспалительных агентов | |
| JP2014513110A5 (enExample) | ||
| TW201726606A (zh) | 作為免疫調節劑之化合物 | |
| RU2008133383A (ru) | Производные гидантоина для лечения воспалительных заболеваний | |
| JP2011527331A5 (enExample) | ||
| CA2672373A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| TW200838497A (en) | Sphingosine-1-phosphate receptor agonist and antagonist compounds | |
| JP2010524932A5 (enExample) | ||
| JP2013545808A5 (enExample) | ||
| JP2022510925A5 (enExample) | ||
| RU2009102943A (ru) | Производные фенола для лечения респираторных заболеваний | |
| JP2018536648A5 (enExample) | ||
| HRP20231608T1 (hr) | Derivati piridinil sulfonamida, njihovi farmaceutski pripravci i njihove uporabe | |
| RU2010117156A (ru) | Гетероциклические соединения в качестве антагонистов crth2 рецептора | |
| CN113354585B (zh) | 新型ep4拮抗剂的合成及其在癌症和炎症中的用途 |